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Analogues of the NPY model pcptide NPY l-4-Aca-25-36 were synthesized by solid phase peptide synthesis using the tea-bag method for parallel 
pcptide synthesis. The affinity of the peptides as ligands to the NPY receptor in rat cerebral cortex was investigated. The model compound NPY 
l-4-Aca-25-36 was a relatively poor ligand to the NPY receptor in rat brain (IC& = 0.40 PM). A@ and Arg3 were both important for ligand 
recognition by the NPY receptor. Substitutions in several positions in the region corresponding to the C-terminal part of NPY resulted in analogues 
with only minor reduction of the affinity for the NPY receptor. 
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1. INTRODUCTION 
Neuropeptide Y (NPY) is a 36 amino acid long pep- 
tide first isolated from porcine brain by Tatemoto et al. 
[1,2]. NPY is a member of the so-called pancreatic 
polypeptide family of which also the peptides PYY and 
pancreatic polypeptide (PP) have been isolated from 
mammalian sources [3,4]. The PP family is characteris- 
ed by a stable tertiary structure in water solution [5] 
rendering the members of this peptide hormone family 
one of the smallest globular proteins. X-Ray crystallo- 
graphic studies of avian pancreatic polypeptide (APP) 
[6] have shown that the structure can be divided into a 
polyproline helix (residues l-S), a bend region (g-14), 
an a-helix (14-30) and a flexible C-terminal hexa- 
peptide. The packing and interdigitating of hydro- 
phobic residues in the polyproline-helix and the a-helix 
stabilises the tertiary structure. Receptors for NPY have 
been characterised in the central nervous system [7], in 
the spleen [8] and in various cell lines [9]. Two subtypes 
of NPY receptors have been suggested based on dif- 
ferent pre- and post-junctional pharmacological actions 
of the C-terminal fragment NPY 13-36 [lo]. 
amino acid long analogue where amino acids in the 
bend region had been deleted and the structure was 
stabilised by a disulfide bridge. This analogue bound to 
membranes from mouse brain with the same affinity as 
the native hormone. Another 17 amino acid long 
analogue NPY l-4-Aca-25-36 was designed by Beck et 
al. [12] which bound to rabbit kidney membranes with 
only slightly reduced affinity as compared to NPY l-36. 
Relatively few structure/activity studies of NPY and 
other members of the pancreatic polypeptide family 
have been carried out, but it has been shown that the C- 
terminal amide is of critical importance for binding and 
biological activity [ 10,131. Gln34 has been shown to be 
important for recognition by the YZ receptor subtype 
but not by the Yi subtype [9]. 
In the present study the NPY analogue NPY 1-4- 
Aca-25-36 and analogues containing substitutions in the 
region 25-36 were studied as ligands to the NPY recep- 
tor in rat cerebral cortex. 
2. MATERIALS AND METHODS 
Attempts have been made to synthesize shorter 
fragments of NPY which still bind to the NPY receptor 
with high affinity. Krstenansky et al. [l l] designed a 27 
2.1. Reagents 
Correspondence address: A. Unden, Department of Biochemistry, 
Arrhenius Laboratory, Stockholm University, S-10691 Stockholm, 
Sweden 
t-BOC D-Arg(Tos) was purchased from Bachem, Switzerland. All 
other t-BOC amino acids were purchased from Peninsula, UK. Thep- 
methylbenzhydrylamine r sin (0.8 mmol of amine/g, 100-200 mesh), 
dicyclohexylcarbodiimide (DCC) and I-hydroxy-benzotriazol (HOBt) 
were from Fluka, Switzerland. ‘H-Propionyl NPY (50 Ci/mmol) was 
purchased from Amersham, UK. NPY was obtained from Bachem. 
All other chemicals were of reagent grade. 
Abbreviations: Aca, +aminocaproic acid; APP, avian pancreatic 
polypeptide; t-BOC, tert-butyloxycarbonyl; BSA, bovine serum 
albumin; Hepes, (N-[2-hydroxyethyl] piperazine-N’ -[Zethane- 
sulfonic acid]; PP, pancreatic polypeptide 
2.2. Peptide synthesis 
Solid phase peptide synthesis was carried out by the so-called tea- 
bag method for parallel peptide synthesis developed by Houghten 
[14]. All amino acids were coupled with DCC in a 1: 1 molar ratio, ex- 
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Table 1 
Amino acid substitutions in the sequence of the NPY model peptide 
NPY 1-4-Aca-25-36 [12] and their affinities as ligands to the NPY 
counted in a liquid scintillation spectrometer. The I&,, values were 
calculated by nonlinear regression analysis. 
receptor in rat cerebral cortex 
Analogues of NPY 1-4-Aca-25-36 as ligands to NPY-receptors in rat 3. RESULTS AND DISCUSSION 
cerebral cortex. 
Peptide Go W) Relative affinity 
1-4-Aca-25-36 0.4 f 0.2 1.0 
l-4-Aca-25-36(D-Y’6) 0.6 f 0.01 0.7 
1-4-Aca-25-36(D-R’s) 1.1 f 0.7 0.4 
1-4-Aca-25.36(K”) >30 <O.Ol 
1-4-Aca-25-36(A34) 3.1 t 0.3 0.1 
1-4-Aca-25-36(P34) 3.6 + 2 0.1 
l-4-Aca-25-36(H34) 0.4 + 0.2 1.0 
1-4-Aca-25-36(D-R33) 0.9 + 0.3 0.4 
l-4-Aca-25-36(A33) >30 <O.Ol 
1-4-Aca-25-36(V)‘) 1.6 t 0.3 0.3 
l-4-Aca-25-36(A29) 2.0 k 0.8 0.2 
l-4-Aca-25-36(A26) 1.2 + 0.5 0.3 
l-4-Aca-25-36(AZ5) 0.7 + 0.1 0.6 
The analogue NPY l-4-Aca-25-36 binds to the NPY 
receptor in membranes from rat cerebral cortex with an 
1C50 value of 0.4 PM (Table I) which has 3 orders of 
magnitude lower affinity as compared to the original 
report by Beck et al. on binding of this analogue to 
NPY receptors from kidney membranes [12]. 
ND, not determined. The I&O values were determined in equilibrium 
binding experiments with [3H]propionyl NPYi _ 36. I&O values are the 
mean of at least 4 different experiments i SD. 
The relatively low affinity of the parent analogue 
NPY l-4-Aca-25-36 for brain NPY receptors is in agree- 
ment with results recently reported by McLean et al. 
[ 161 where NPYzo _ 36 bound to NPY receptors from pig 
spleen with two orders of magnitude higher affinity as 
compared with binding to NPY receptors from mouse 
brain. These data suggest hat the NPY receptors in 
brain membranes have a different structural require- 
ment for ligand recognition than the NPY receptors 
from spleen and kidney. 
cept for Gln, Arg and His which were coupled as HOBt esters. Side 
chain protection of amino acids were - arginine: tosyl; histidine: ben- 
zyloxymethyl; lysine: 2-chlorobenzoyloxycarbonyl; serine/threonine: 
benzyl; tyrosine: 2-bromobenzyloxycarbonyl; D-tyrosine: 1,6- 
dichlorobenzyl. The analogues were cleaved from the resin by 
hydrogen fluoride. 
The results presented in Table I show that substitu- 
tions in several positions of the model peptide NPY 
l-4-Aca-25-36 only resulted in minor reduction in af- 
finity. 
The crude peptides were purified by reversed-phase HPLC, on a 
Cis Ultropac column (7.8 x 300 mm, 1Orm particles; TSK ODS 120T, 
LKB, Sweden). Amino acid analysis was performed on hydrolysed 
peptides by the gas-phase hydrolysis method [15] followed by 
phenylisothiocyanate (PITC) derivatization. The phenylthiocarbamyl 
(PTC) derivatives were eluted with a gradient of 50% acetonitrile in 
12.5 mM sodium phosphate buffer, pH 6.4, from a reversed-phase 
cl8 Superpac column (4X 125 mm, 3 gm particle size; Spherisorb 
ODS 2, Pharmacia, Sweden). 
The arginines in positions 33 and 35 are both impor- 
tant for ligand binding to the NPY receptor. Substitu- 
tions such as LYS~~ and Ala33 both resulted in analogues 
where no displacement could be detected in concentra- 
tions up to 30pM. 
2.3. Receptor binding studies 
Receptor binding studies were performed according to Unden et al. 
[7] with slight modifications. Adult male rats (Sprague-Dawley, 
180-200 g) were decapitated, the brain rapidly removed and the 
cerebral cortex dissected. The tissue was homogenized with a loose- 
fitting glass teflon homogenizer in 10 vols ice-cold 0.32 M sucrose. 
The homogenate was centrifuged at 1000 x g for 5 min, the superna- 
tant collected and centrifuged at 10000x g for 40 min. The pellet was 
resuspended in ice-cold Krebs-Ringer buffer (137 mM NaCl, 2.68 mM 
KCI, 1.8 mM CaCl2, 1.05 mM MgCl2, 1 g/l glucose; 0.5 g/l BSA, 20 
mM Hepes, pH 7.4; bacitracin 0.02%). The homogenate (0.2 mg pro- 
tein) was incubated at room temperature for 90 min with [3H]NPY 
(0.4 nM final concentration) and different concentrations of the 
ligands in a final volume of 1 ml. Nonspecific binding was defined as 
the binding in the presence of 100 nM unlabeled NPY. After incuba- 
tion the samples were centrifuged at 1OOOOxg for 30 s, the superna- 
tant was aspirated and the bottom of the tubes were cut off and 
Several studies have shown that short C-terminal 
fragments of NPY are poor ligands to NPY receptors 
from the mammalian central nervous system. This in- 
dicates that residues in the region l-32 are of critical im- 
portance for ligand recognition by brain NPY recep- 
tors. Two basic residues ArgZS and His26 are conserved 
either as Arg-His or Arg-Arg in all members of the PP 
family. The result in Table I shows that substitutions in 
these positions with alanine resulted only in minor 
reductions of the affinity. 
It can be concluded that NPY l-4-Aca-25-36 is not an 
ideal model peptide for NPY receptors from rat brain. 
On the other hand, to carry out structure/activity rela- 
tion studies in the C-terminal part of the 36 amino acid 
long peptide is associated with extensive synthesis work. 
It is also likely that results obtained with shorter 
analogues such as substituted NPY l-4-Aca-25-36 
analogues reflect the structural requirement of recogni- 
tion of the C-terminal of the native hormone NPY I -36. 
1 10 20 30 
Porcine NPY YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRYNH2 
NPY- l-4-Aca-25-36 Y p S K _ _ - - _ _ _ _ _ _ _ _ - - Aca_ _ _ _ _ _ _ _ _ _ _ _ R H Y IN L IT R Q R Y -NH2 
Fig. 1. Primary structure of porcine neuropeptide Y (NPY) and the analogue NPY I-4-Aca-25-36. 
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